迈克生物 (300463)

Maccura Biotechnology Co.,Ltd

ASZ

Tags

Humanoid RobotsMedical DevicesGene ConceptHelicobacter PyloriLow-Profit StocksIntelligent MachinesSocial Security HeavyChiNext 200 IndexChiNext InnovationChiNext HealthcareShenzhen ConnectTech 100 IndexCSFC HoldingsSZSE Medicine Equal Weight IndexSina 100 IndexShenzhen A-Share Pharmaceutical IndexCS High Dividend Yield IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexSZSE 1000 IndexCSSW Health IndexSZSE Component Index ReturnCSWD Life Sciences IndexCS Precision Medicine IndexZhongchuang Value IndexNew Virus PreventionCOVID-19 PreventionAugust 2022 Lock-up ExpiryAntigen Self-testGene SequencingCOVID-19 TestingFTSE Russell ConceptStocks Below Book ValuePrecision MedicineJune 2021 Lock-up ExpiryPublic Health IndexSME Board Innovation IndexCS Pharmaceutical TI IndexCSI 1000 IndexChiNext Basic IndexSZSE Component Pharmaceutical IndexChiNext Low Volatility IndexSZSE Component Index Equal WeightPharmaceutical & Health 100 IndexZhongchuang Low Volatility IndexCSI Life Sciences IndexCICC 300 IndexZhongchuang 400 IndexCSI 1000 Value IndexSichuan

K-Line Chart

No K-line data available

Company NameMaccura Biotechnology Co., Ltd.
Listing Date2015-05-28
Issue Price27.96RMB
Registered Capital60466.662410k RMB
Legal RepresentativeTang Yong
Registered AddressNo. 16 Baichuan Road, High-tech Zone, Chengdu City, Sichuan Province
IndustryMedical Devices
Main BusinessResearch, development, production, sales and service of in vitro diagnostic products
Company ProfileFounded in 1994, Maccura Biotechnology Co., Ltd. has always focused on the research, production, sales and service of in vitro diagnostic products. We are a "High-tech Enterprise" certified by relevant national authorities, and have successively passed CMD ISO13485, CQC ISO14001, TUV ISO13485 certifications and CE certification for some products. We possess world-class R&D, production, and management operation teams; have completed a full industry chain development layout from biological raw materials and medical laboratory products to professional services; possess systematic professional capabilities in R&D and manufacturing of in vitro diagnostic equipment, reagents, calibrators, and quality control materials; our products cover biochemical, immunoassay, rapid testing, hematology, molecular diagnostics, pathology and other technology platforms, and through product integration, meet over 90% of the needs of medical laboratories.

Stock Details

1. Key Indicators

  • Total Shares(W): 60466.66
  • Circulating A-Shares(W): 49180.02
  • Earnings Per Share(RMB): 0.0606
  • Net Assets Per Share(RMB): 10.4622
  • Operating Revenue(W RMB): 160788.41
  • Total Profit(W RMB): 3450.18
  • Net Profit Attributable to Parent(W RMB): 3710.34
  • Net Profit Growth Rate(%): -86.81
  • Weighted Return on Equity(%): 0.5800
  • Operating Cash Flow Per Share(RMB): 0.5130
  • Undistributed Profit Per Share(RMB): 6.3622
  • Capital Reserve Per Share(RMB): 2.5950

2. Main Business

The main business covers:

  • Research, development, production, sales, and related services of in vitro diagnostic products

3. Company Basic Information

  • Company Name: Maccura Biotechnology Co., Ltd.
  • Listing Date: 2015-05-28
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 1006, Qihuang 1st Road, Shuangliu District, Chengdu City, Sichuan Province
  • Website: www.maccura.com
  • Company Profile：The company's predecessor was Sichuan Maccura Technology Co., Ltd., established on October 20, 1994, with a registered capital of 1 million yuan. The company was initiated and established by Sichuan Maccura Technology Co., Ltd. through an overall change. Approved by the resolution of the temporary shareholders' meeting of Maccura Technology on November 18, 2009, and the resolution of the company's founding meeting on November 22, 2009, Maccura Technology was wholly changed into Sichuan Maccura Biotechnology Co., Ltd. According to the Zhonghe Zhengxin Audit Report No. 12-2068 (2009) issued by Zhonghe Zhengxin Certified Public Accountants, based on the audited net assets of Maccura Technology as of May 31, 2009, amounting to RMB 63,709,343.31, the company's shares were converted at a ratio of 1:0.6883 into 43.85 million shares, with the remaining RMB 19,859,343.31 credited to capital reserve. Lixin Certified Public Accountants issued the Capital Verification Report No. Xinhui Shi Bao Zi (2009) No. 24684 for the establishment of the joint-stock company through this overall change, confirming that as of November 22, 2009, the total capital contribution of RMB 43.85 million by all shareholders of the company had been fully paid. On December 7, 2009, the company was registered with the Sichuan Provincial Administration for Industry and Commerce, obtaining the business license with registration number 510000000104554, with a registered capital of 43.85 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 China Merchants Securities Asset Management-Sun Li-CMB Asset Management Zhenxiang Value 2025001 Single Asset Management Plan Asset Management Plan 1005.46 2.04
2 CITIC Securities Asset Management (Hong Kong) Limited - Client Funds Asset Management Plan 469.47 0.95
3 Hong Kong Securities Clearing Company Ltd. Northbound Funds 441.26 0.90

5. Concept Sectors

  • Intelligent Machines
  • Gene Concept
  • Helicobacter Pylori
  • Hepatitis Concept
  • Humanoid Robots
  • AI Healthcare
  • Margin Trading & Securities Lending
  • Low-Profit Stocks
  • ChiNext Healthcare
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information